VEGF R1/FLT-1[Biotin], His&Avi, Human
| $650.00 | |
| Z03969-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $650.00 | |
| Z03969-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||||
| Protein Construction |
|
||||||
| Conjugate | Biotin | ||||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||||
| Biological Activity | Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch. | ||||||
| Expression System | HEK293 | ||||||
| Theoretical Molecular Weight | 85.1 kDa | ||||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 100-120 kDa based on Bis-Tris PAGE result. | ||||||
| Formulation | Lyophilized from a 0.22 μm filtered solution in PBS, (pH 7.4). | ||||||
| Reconstitution | It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml. | ||||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
VEGF R1/FLT-1[Biotin], His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Immobilized Human VEGF165, No Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for VEGF R1/FLT-1[Biotin], His & Avi, Human with the EC50 of 24.0 ng/ml determined by ELISA. »
Immobilized Human PGF at 0.5 mg/ml(100 ml/Well) on the plate. Dose response curve for VEGF R1/FLT-1[Biotin], His&Avi, Human, His Tag with the EC50 of 48 ng/ml determined by ELISA. »
| Target Background | Vascular endothelial growth factor receptor 1(VEGFR1), also known as Flt-1, is a type I transmembrane glycoprotein of receptor tyrosine kinases (RTKs) family. VEGFR1 acts as a cell-surface receptor for VEGFA, VEGFB and PGF. It plays an important role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration and cancer cell invasion. |
| Synonyms | FLT; FLT1; Flt-1; FRT; VEGF R1; VEGFR1 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.